United States · FDA National Drug Code directory
Busulfan
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51817-170_df501797-3c7e-5ae2-e053-2995a90a99e8
- Product NDC
- 51817-170
- Form
- INJECTION
- Composition / generic term
- busulfan
- Labeler
- Pharmascience Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170519
- Source listing expiry
- 20261231
Source-listed ingredients
- BUSULFAN — 6 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 8 VIAL in 1 PACKAGE (51817-170-01) / 10 mL in 1 VIAL · 51817-170-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →